{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:43:36Z","timestamp":1761893016524},"reference-count":46,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"DOI":"10.1210\/jc.2013-4519","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T11:10:02Z","timestamp":1394449802000},"page":"2225-2232","source":"Crossref","is-referenced-by-count":6,"title":["Glucose Turnover After Replacement of Usual Therapy by Insulin in Insulin-naive Type 2 Diabetes Subjects"],"prefix":"10.1210","volume":"99","author":[{"given":"H.","family":"Thabit","sequence":"first","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kumareswaran","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Haidar","sequence":"additional","affiliation":[{"name":"Centre for Intelligent Machines (A.H.), McGill University, Montreal, Quebec H3A 0E9, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Leelarathna","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Caldwell","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Elleri","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"},{"name":"Wellcome Trust-Medical Research Council Institute of Metabolic Science, and Department of Paediatrics (D.E., J.M.A., M.E.W., R.H.), University of Cambridge, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Allen","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"},{"name":"Wellcome Trust-Medical Research Council Institute of Metabolic Science, and Department of Paediatrics (D.E., J.M.A., M.E.W., R.H.), University of Cambridge, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nodale","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Wilinska","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"},{"name":"Wellcome Trust-Medical Research Council Institute of Metabolic Science, and Department of Paediatrics (D.E., J.M.A., M.E.W., R.H.), University of Cambridge, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. C.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Postgraduate Medical School (N.C.J., A.M.U.), University of Surrey, Guildford GU2 7TE, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Umpleby","sequence":"additional","affiliation":[{"name":"Postgraduate Medical School (N.C.J., A.M.U.), University of Surrey, Guildford GU2 7TE, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Evans","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hovorka","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (H.T., K.K., L.L., K.C., D.E., J.M.A., M.N., M.E.W., M.L.E., R.H.), Cambridge CB2 0QQ, United Kingdom;"},{"name":"Wellcome Trust-Medical Research Council Institute of Metabolic Science, and Department of Paediatrics (D.E., J.M.A., M.E.W., R.H.), University of Cambridge, Cambridge CB2 0QQ, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113335551100_B1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1185\/03007990903566822","article-title":"Addressing hyperglycemia from hospital admission to discharge","volume":"26","author":"Moghissi","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t2019041113335551100_B2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","article-title":"NHS Diabetes guideline for the perioperative management of the adult patient with diabetes","volume":"29","author":"Dhatariya","year":"2012","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t2019041113335551100_B3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3810\/pgm.2008.11.1937","article-title":"Hyperglycemia management in the hospital: about glucose targets and process improvements","volume":"120","author":"Juneja","year":"2008","journal-title":"Postgrad Med"},{"key":"key\n\t\t\t\t2019041113335551100_B4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2337\/dc12-2508","article-title":"Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action","volume":"36","author":"Draznin","year":"2013","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3810\/pgm.2010.01.2109","article-title":"The nuts and bolts of subcutaneous insulin therapy in non-critical care hospital settings","volume":"122","author":"Juneja","year":"2010","journal-title":"Postgrad Med"},{"key":"key\n\t\t\t\t2019041113335551100_B8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMcp060094","article-title":"Clinical practice. Management of hyperglycemia in the hospital setting","volume":"355","author":"Inzucchi","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113335551100_B9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2013.02.006","article-title":"Metformin revisited: A critical review of the benefit-risk balance in at-risk patients with type 2 diabetes","volume":"39","author":"Scheen","year":"2013","journal-title":"Diabetes Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00125-006-0273-9","article-title":"Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?","volume":"49","author":"Radziuk","year":"2006","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2337\/dc08-1826","article-title":"Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism","volume":"32","author":"Basu","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00400639","article-title":"Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM","volume":"38","author":"Dinneen","year":"1995","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3810\/pgm.2012.11.2614","article-title":"Evolving therapeutic options for type 2 diabetes mellitus: an overview","volume":"124","author":"Guthrie","year":"2012","journal-title":"Postgrad Med"},{"key":"key\n\t\t\t\t2019041113335551100_B14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.metabol.2004.07.014","article-title":"Effect of repaglinide and gliclazide on postprandial control of endogenous glucose production","volume":"54","author":"Singhal","year":"2005","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113335551100_B15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/db07-0827","article-title":"Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes","volume":"57","author":"Basu","year":"2008","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113335551100_B16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0026-0495(97)90307-3","article-title":"Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients","volume":"46","author":"F\u00e9ry","year":"1997","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113335551100_B17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.metabol.2013.05.001","article-title":"Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes","volume":"62","author":"Gastaldelli","year":"2013","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113335551100_B18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00125-012-2738-3","article-title":"Direct effect of GLP-1 infusion on endogenous glucose production in humans","volume":"56","author":"Seghieri","year":"2013","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B19","article-title":"Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomised controlled study [published online September 11, 2013]","author":"Kumareswaran","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B20","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1152\/ajpendo.00581.2011","article-title":"Validity of triple- and dual-tracer techniques to estimate glucose appearance","volume":"302","author":"Haidar","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cmpb.2012.01.010","article-title":"Estimating postprandial glucose fluxes using hierarchical Bayes modelling","volume":"108","author":"Haidar","year":"2012","journal-title":"Comput Methods Programs Biomed"},{"key":"key\n\t\t\t\t2019041113335551100_B22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/(SICI)1096-9888(199609)31:9<961::AID-JMS359>3.0.CO;2-H","article-title":"Quantitative measurement of 3-O-methyl-d-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo","volume":"31","author":"Shojaee-Moradie","year":"1996","journal-title":"J Mass Spectrom"},{"key":"key\n\t\t\t\t2019041113335551100_B23","doi-asserted-by":"crossref","first-page":"E992","DOI":"10.1152\/ajpendo.00304.2001","article-title":"Partitioning glucose distribution\/transport, disposal, and endogenous production during IVGTT","volume":"282","author":"Hovorka","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B24","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.1152\/ajpendo.00546.2006","article-title":"Calculating glucose fluxes during meal tolerance test: a new computational approach","volume":"293","author":"Hovorka","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1008929526011","article-title":"WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility","volume":"10","author":"Lunn","year":"2000","journal-title":"Stat Comput"},{"key":"key\n\t\t\t\t2019041113335551100_B26","first-page":"E400","article-title":"Estimation of the rate of appearance in the non-steady state with a two-compartment model","volume":"263","author":"Mari","year":"1992","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t2019041113335551100_B27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-011-2363-6","article-title":"Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy","volume":"55","author":"Murphy","year":"2012","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B28","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00125-013-2852-x","article-title":"Absorption patterns of meals containing complex carbohydrates in type 1 diabetes","volume":"56","author":"Elleri","year":"2013","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/138920011794520053","article-title":"Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice","volume":"12","author":"Abe","year":"2011","journal-title":"Curr Drug Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPAR\u03b3 stimulation of ENaC-mediated renal salt absorption","volume":"11","author":"Guan","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019041113335551100_B32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1463-1326.2011.01496.x","article-title":"Variations in tissue selectivity amongst insulin secretagogues: a systematic review","volume":"14","author":"Abdelmoneim","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2265.2010.03811.x","article-title":"Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with type 2 diabetes: a double tracer OGTT study","volume":"73","author":"Glass","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113335551100_B34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2165\/11598080-000000000-00000","article-title":"Clinical pharmacokinetics and pharmacodynamics of vildagliptin","volume":"51","author":"He","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t2019041113335551100_B35","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/diabetes.53.8.2169","article-title":"Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes","volume":"53","author":"Tiikkainen","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113335551100_B36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/db11-1067","article-title":"Insulin augmentation of glucose-stimulated insulin secretion is impaired in insulin-resistant humans","volume":"61","author":"Halperin","year":"2012","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113335551100_B37","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0026-0495(83)90034-3","article-title":"Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion","volume":"32","author":"Kraegen","year":"1983","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t2019041113335551100_B38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0028-1093496","article-title":"Failure of exogenous insulin to inhibit insulin secretion in man","volume":"9","author":"Shima","year":"1977","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t2019041113335551100_B39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2337\/diab.36.8.959","article-title":"Insulin suppresses its own secretion in vivo","volume":"36","author":"Argoud","year":"1987","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113335551100_B40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1463-1326.2012.01647.x","article-title":"Modulation of \u03b2-cell function: a translational journey from the bench to the bedside","volume":"14","author":"Goldfine","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dom.12117","article-title":"Hepatoselectivity and the evolution of insulin","volume":"16","author":"Herring","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"key\n\t\t\t\t2019041113335551100_B42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-005-1670-1","article-title":"Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clamp","volume":"48","author":"Hordern","year":"2005","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B43","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.2337\/dc12-2072","article-title":"Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study","volume":"36","author":"Solis-Herrera","year":"2013","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B44","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041113335551100_B45","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113335551100_B46","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2337\/diabetes.51.7.2179","article-title":"Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects","volume":"51","author":"Hawkins","year":"2002","journal-title":"Diabetes"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/6\/2225\/9049995\/jcem2225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T08:54:34Z","timestamp":1565254474000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/6\/2225\/2537951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-4519","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,1]]}}}